CTOs on the Move

Middle Peninsula-Northern Neck Community Service

www.mpnncsb.org

 
The Middle Peninsula Northern Neck Community Services Board is a public, nonprofit organization providing services to meet the needs of individuals and their families who have problems associated with mental health, intellectual disabilities, substance abuse, and developmental disabilities. Services are provided to residents in the Middle Peninsula and Northern Neck, VA. This area includes the counties of Westmoreland, Richmond, Essex, Northumberland, Lancaster, Gloucester, Mathews, Middlesex King & Queen and King William. It also includes the Town of Colonial Beach and West Point.
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.mpnncsb.org
  • 9228 George Washington Memorial Hwy
    Gloucester, VA USA 23061
  • Phone: 804.693.5057

Executives

Name Title Contact Details

Similar Companies

Caduceus Marketing Research

Caduceus Marketing Research is a Mount Arlington, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Red Mountain Behavioral Health

Red Mountain Behavioral Health is a Mesa, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Georgia Medical Care Foundation

Since 1972, GMCF has been providing medical peer review and consultative services, utilization and quality management review services for Medicaid Programs.

St. John's Hospital

St. John's Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St. John's Hospital is based in Springfield, IL. You can find more information on St. John's Hospital at www.st-johns.org

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.